{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:54:52Z","timestamp":1781542492694,"version":"3.54.5"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>SLE and ME\/CFS both present significant fatigue and share immune dysregulation. The mechanisms underlying fatigue in these disorders remain unclear, and there are no standardized treatments. This study aims to explore shared mechanisms and predict potential therapeutic drugs for fatigue in SLE and ME\/CFS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Genes associated with SLE and ME\/CFS were collected from disease target and clinical sample databases to identify overlapping genes. Bioinformatics analyses, including GO, KEGG, PPI network construction, and key target identification, were performed. ROC curve and correlation analysis of key targets, along with single-cell clustering, were conducted to validate their expression in different cell types. Additionally, an inflammation model was established using THP-1 cells to simulate monocyte activation in both diseases <jats:italic>in vitro<\/jats:italic>, and RT-qPCR was used to validate the expression of the key targets. A TF-mRNA-miRNA co-regulatory network was constructed, followed by drug prediction and molecular docking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-eight overlapping genes were identified, mainly involved in innate immunity and inflammation. Five key targets were identified (IL1\u03b2, CCL2, TLR2, STAT1, IFIH1). Single-cell sequencing revealed that monocytes are enriched with these targets. RT-qPCR confirmed significant upregulation of these targets in the model group. A co-regulatory network was constructed, and ten potential drugs, including suloctidil, N-Acetyl-L-cysteine, simvastatin, ACMC-20mvek, and camptothecin, were predicted. Simvastatin and camptothecin showed high affinity for the key targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SLE and ME\/CFS share immune and inflammatory pathways. The identified key targets are predominantly enriched in monocytes at the single-cell level, suggesting that classical monocytes may be crucial in linking inflammation and fatigue. RT-qPCR confirmed upregulation in activated monocytes. The TF-mRNA-miRNA network provides a foundation for future research, and drug prediction suggests N-Acetyl-L-cysteine and camptothecin as potential therapies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1440922","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:53:14Z","timestamp":1736232794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the shared mechanism of fatigue between systemic lupus erythematosus and myalgic encephalomyelitis\/chronic fatigue syndrome: monocytic dysregulation and drug repurposing"],"prefix":"10.3389","volume":"15","author":[{"given":"Daisi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.6.379","article-title":"Factors associated with fatigue in patients with systemic lupus erythematosus","volume":"58","author":"Bruce","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/lupus-2020-000469","article-title":"Living with systemic lupus erythematosus in 2020: a European patient survey","volume":"8","author":"Cornet","year":"2021","journal-title":"Lupus Sci Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8640-5","article-title":"Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus","volume":"55","author":"Bakshi","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B5","article-title":"A study of fatigue in systemic lupus erythematosus","volume":"17","author":"Krupp","year":"1990","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312459105","article-title":"Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics","volume":"29","author":"Omdal","year":"2002","journal-title":"J Rheumatol"},{"key":"B7","article-title":"Fatigue in lupus is not correlated with disease activity","volume":"25","author":"Wang","year":"1998","journal-title":"J Rheumatol"},{"key":"B8","article-title":"Chronic fatigue syndrome: diagnosis and treatment","volume":"86","author":"Yancey","year":"2012","journal-title":"Am Fam Physician"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1386607","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: the biology of a neglected disease","volume":"15","author":"Arron","year":"2024","journal-title":"Front Immunol"},{"key":"B10","article-title":"Disclosure: Priyanka Bhandari declares no relevant financial relationships with ineligible companies","volume-title":"Chronic fatigue syndrome","author":"Sapra","year":"2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-244X-9-S1-S1","article-title":"Chronic fatigue syndrome: aetiology, diagnosis and treatment","author":"Avellaneda Fern\u00e1ndez","year":"2009","journal-title":"BMC Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijerph182010736","article-title":"Network analysis of symptoms co-occurrence in chronic fatigue syndrome","volume":"18","author":"Kujawski","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(97)80015-5","article-title":"Systemic Lupus Erythematosus (SLE) lymphadenopathy presenting with histopathologic features of castleman Disease: A Clinicopathologic Study of Five Cases","volume":"193","author":"Kojima","year":"1997","journal-title":"Pathol  Res Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s42358-020-00144-6","article-title":"Active human herpesvirus infections in adults with systemic lupus erythematosus and correlation with the SLEDAI score","volume":"60","author":"Reis","year":"2020","journal-title":"Adv Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/v13020277","article-title":"Viral infections and systemic lupus erythematosus: new players in an old story","volume":"13","author":"Quaglia","year":"2021","journal-title":"Viruses"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294758","article-title":"Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME\/CFS progression","volume":"14","author":"Berkis","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome \u2013 Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"101373","DOI":"10.1016\/j.xcrm.2023.101373","article-title":"Single-cell transcriptomics of the immune system in ME\/CFS at baseline and following symptom provocation","volume":"5","author":"Vu","year":"2024","journal-title":"Cell Rep Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12864-023-09275-8","article-title":"Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy","volume":"24","author":"Nikolakis","year":"2023","journal-title":"BMC Genomics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1021","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/0471250953.2016.54.issue-1","article-title":"The geneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinf"},{"key":"B23","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The Gene Ontology resource: enriching a GOld mine","volume":"49","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41598-022-27310-8","article-title":"High throughput sequencing revealed enhanced cell cycle signaling in SLE patients","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0212193","DOI":"10.1371\/journal.pone.0212193","article-title":"Whole blood human transcriptome and virome analysis of ME\/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing","volume":"14","author":"Bouquet","year":"2019","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0743-0","article-title":"Mapping systemic lupus erythematosus heterogeneity at the single-cell level","volume":"21","author":"Nehar-Belaid","year":"2020","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms252011011","article-title":"Pyrimidine derivatives as selective COX-2 inhibitors with anti-inflammatory and antioxidant properties","volume":"25","author":"Tyli\u0144ska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/wasj.2020.32","article-title":"Transcription factors and evolution: An integral part of gene expression (Review)","volume":"2","author":"Mitsis","year":"2020","journal-title":"World Acad Sci J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s42003-021-02153-7","article-title":"Transcription factor enrichment analysis (TFEA) quantifies the activity of multiple transcription factors from a single experiment","volume":"4","author":"Rubin","year":"2021","journal-title":"Commun Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: An online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"D304","DOI":"10.1093\/nar\/gkad1071","article-title":"TarBase-v9.0 extends experimentally supported miRNA-gene interactions to cell-types and virally encoded miRNAs","volume":"52","author":"Skoufos","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/bph.v174.5","article-title":"Treatment and management of chronic fatigue syndrome\/myalgic encephalomyelitis: all roads lead to Rome","volume":"174","author":"Castro-Marrero","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 Contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0217","article-title":"Increased circulating interleukin-8 levels in systemic lupus erythematosus patients: a meta-analysis","volume":"12","author":"Mao","year":"2018","journal-title":"biomark Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00035","article-title":"Clearance deficiency and cell death pathways: A model for the pathogenesis of SLE","volume":"7","author":"Mahajan","year":"2016","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.08.026","article-title":"The role of Tumor Necrosis Factor-alpha (TNF-\u03b1) in the pathogenesis of systemic lupus erythematosus","volume":"56","author":"Postal","year":"2011","journal-title":"Cytokine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J Transl Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12967-020-02560-0","article-title":"Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis\/chronic fatigue syndrome: a pilot study","volume":"18","author":"Giloteaux","year":"2020","journal-title":"J Trans Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12967-024-05148-0","article-title":"Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis\/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study","volume":"22","author":"Domingo","year":"2024","journal-title":"J Transl Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(91)90497-2","article-title":"Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome","volume":"3","author":"Chao","year":"1991","journal-title":"Cytokine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"104578","DOI":"10.1016\/j.psyneuen.2019.104578","article-title":"The role of low-grade inflammation in ME\/CFS (Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome) - associations with symptoms","volume":"113","author":"Jonsj\u00f6","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"B50","article-title":"The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation","volume":"28","author":"Maes","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.09.005","article-title":"IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection","volume":"108","author":"Bellmann-Weiler","year":"2008","journal-title":"J Affect Disord"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s11136-014-0656-1","article-title":"Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update","volume":"23","author":"Sprangers","year":"2014","journal-title":"Qual Life Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","article-title":"The neuroimmune basis of fatigue","volume":"37","author":"Dantzer","year":"2014","journal-title":"Trends Neurosci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12974-017-0796-7","article-title":"Interleukin-1 as a mediator of fatigue in disease: a narrative review","volume":"14","author":"Roerink","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease\u2013associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain Behav Immun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.bbih.2020.100067","article-title":"MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls","volume":"4","author":"Groven","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2174\/1871527314666150317224645","article-title":"The toll-like receptor radical cycle pathway: A new drug target in immune-related chronic fatigue","volume":"14","author":"Kurt","year":"2015","journal-title":"CNS Neurol Disord  Drug Targets"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00079","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161759","article-title":"Recurrent rhinovirus infections in a child with inherited MDA5 deficiency","volume":"214","author":"Lamborn","year":"2017","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00012","article-title":"Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Chu","year":"2019","journal-title":"Front Pediatr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/ijms23084095","article-title":"STAT1 and its crucial role in the control of viral infections","volume":"23","author":"Tolomeo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"155633","DOI":"10.1016\/j.cyto.2021.155633","article-title":"Abnormalities of the type I interferon signaling pathway in lupus autoimmunity","volume":"146","author":"Gallucci","year":"2021","journal-title":"Cytokine"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/ng.468","article-title":"A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus","volume":"41","author":"Gateva","year":"2009","journal-title":"Nat Genet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","article-title":"A balancing act: MDA5 in antiviral immunity and autoinflammation","volume":"27","author":"Dias Junior","year":"2019","journal-title":"Trends Microbiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.7.3959","article-title":"IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway","volume":"165","author":"Tian","year":"2000","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"109765","DOI":"10.1016\/j.clim.2023.109765","article-title":"Transcriptomic and proteomic profiling reveals distinct pathogenic features of peripheral non-classical monocytes in systemic lupus erythematosus","volume":"255","author":"Stergioti","year":"2023","journal-title":"Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1615\/CritRevImmunol.v31.i5.20","article-title":"LPS-induced cytokine production in human monocytes and macrophages","volume":"31","author":"Rossol","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cellimm.2018.07.008","article-title":"Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens","volume":"332","author":"Forrester","year":"2018","journal-title":"Cell Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/labinvest.3700007","article-title":"Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration","volume":"84","author":"Hardy","year":"2004","journal-title":"Lab Invest"},{"key":"B72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.genet.34.1.77","article-title":"Transcription of eukaryotic protein-coding genes","volume":"34","author":"Lee","year":"2000","journal-title":"Annu Rev Genet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41385-018-0108-2","article-title":"Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseases","volume":"12","author":"Guler","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402521","article-title":"Batf2\/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection","volume":"194","author":"Roy","year":"2015","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.10.002","article-title":"Interferon regulatory factors: critical mediators of human lupus","volume":"165","author":"Jensen","year":"2015","journal-title":"Transl Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"607526","DOI":"10.3389\/fcimb.2020.607526","article-title":"The fate of speckled protein 100 (Sp100) during herpesviruses infection","volume":"10","author":"Collados Rodr\u00edguez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.02.023","article-title":"Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study","volume":"90","author":"Lessard","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091420","article-title":"Increased expression of phospholipid scramblase 1 in monocytes from patients with systemic lupus erythematosus","volume":"37","author":"Suzuki","year":"2010","journal-title":"J Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12967-022-03682-3","article-title":"Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12967-017-1201-0","article-title":"Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival","volume":"15","author":"Nguyen","year":"2017","journal-title":"J Transl Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1744-9081-4-44","article-title":"Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood","volume":"4","author":"Aspler","year":"2008","journal-title":"Behav Brain Funct"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-017-0954-5","article-title":"Expression and function of hsa-miR-6165 in human cell lines and during the NT2 cell neural differentiation process","volume":"63","author":"Hassanlou","year":"2017","journal-title":"J Mol Neurosci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2018-0421","article-title":"Hsa-miR-6165 downregulates insulin-like growth factor-1 receptor (IGF-1R) expression and enhances apoptosis in SW480 cells","volume":"401","author":"Hassanlou","year":"2020","journal-title":"Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320944473","article-title":"Discovering the signature of a lupus-related microRNA profile in the Gene Expression Omnibus repository","volume":"29","author":"Omidi","year":"2020","journal-title":"Lupus"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/tap.2018.22.issue-3","article-title":"Changes in the expression of circulating microRNAs in systemic lupus erythematosus patient blood plasma after passing through a plasma adsorption membrane","volume":"22","author":"Ishibe","year":"2018","journal-title":"Ther Apher Dial"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.7150\/jca.29536","article-title":"Hsa-let-7e-5p inhibits the proliferation and metastasis of head and neck squamous cell carcinoma cells by targeting chemokine receptor 7","volume":"10","author":"Wang","year":"2019","journal-title":"J Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"144648","DOI":"10.1016\/j.gene.2020.144648","article-title":"Association of miR-760 with cancer: An overview","volume":"747","author":"Manvati","year":"2020","journal-title":"Gene"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.03.037","article-title":"Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"141","author":"Brenu","year":"2012","journal-title":"J Affect Disord"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.614044","article-title":"MiR-19a-3p suppresses M1 macrophage polarization by inhibiting STAT1\/IRF1 pathway","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"23725","DOI":"10.1038\/s41598-024-74399-0","article-title":"HPV16 E6-induced M2 macrophage polarization in the cervical microenvironment via exosomal miR-204-5p","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/10799893.2020.1818095","article-title":"Up-regulation of MiR-145-5p promotes the growth and migration in LPS-treated HUVECs through inducing macrophage polarization to M2","volume":"41","author":"Su","year":"2021","journal-title":"J Recept Signal Transduct Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1189\/jlb.1A1014-519RR","article-title":"Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity","volume":"98","author":"Fordham","year":"2015","journal-title":"J Leukocyte Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/antiox10060967","article-title":"N-acetylcysteine (NAC): impacts on human health","volume":"10","author":"Ten\u00f3rio","year":"2021","journal-title":"Antioxid (Basel)"},{"key":"B96","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13063-023-07083-9","article-title":"Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study","volume":"24","author":"Abbasifard","year":"2023","journal-title":"Trials"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb07020.x","article-title":"Mechanism of action of camptothecin","volume":"922","author":"Liu","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/art.41685","article-title":"Camptothecin and topotecan, inhibitors of transcription factor fli-1 and topoisomerase, markedly ameliorate lupus nephritis in (NZB \u00d7 NZW)F1 mice and reduce the production of inflammatory mediators in human renal cells","volume":"73","author":"Wang","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619761","article-title":"Camptothecin regulates microglia polarization and exerts neuroprotective effects via activating AKT\/nrf2\/HO-1 and inhibiting NF-\u03baB pathways in vivo and in vitro","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2016.12.023","article-title":"Safe approaches for camptothecin delivery: Structural analogues and nanomedicines","volume":"247","author":"Botella","year":"2017","journal-title":"J Controlled Release"},{"key":"B102","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1210\/jc.2017-01561","article-title":"Statins affect skeletal muscle performance: evidence for disturbances in energy metabolism","volume":"103","author":"Allard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.08.030","article-title":"Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study","volume":"243","author":"Yu","year":"2015","journal-title":"Atherosclerosis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1159\/000077320","article-title":"Lupus-like syndrome associated with statin therapy","volume":"208","author":"No\u00ebl","year":"2004","journal-title":"Dermatology"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90510-0","article-title":"Suloctidil-induced hepatotoxicity","volume":"95","author":"Chung","year":"1988","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1440922\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:53:22Z","timestamp":1736232802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1440922\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":105,"alternative-id":["10.3389\/fimmu.2024.1440922"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1440922","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1440922"}}